Continuous Passive Motion Devices Market: Market Size & Forecast 2026

Continuous Passive Motion devices are mechanical or motorized systems designed to provide continuous, passive movement to joints, primarily the knee, shoulder, and hip, during post-operative recovery or injury rehabilitation. These devices help reduce stiffness, minimize scar tissue formation, and improve functional outcomes by maintaining joint mobility when a patient is unable to actively exercise. The global market was valued at approximately $0.89 billion in 2025 and is expected to grow at a compound annual growth rate of roughly 5.2% through the early 2030s, with the market projected to approach approximately $1.15 billion by 2030 based on this trajectory.

• •CPM therapy is most commonly prescribed following total or partial knee replacement surgery, as well as for ligament reconstruction and rotator cuff repair procedures
• •The market is segmented primarily by joint type (knee, shoulder, hip) and device design (fixed/stationary versus portable/home-use units)
• •Reimbursement policies, clinical evidence supporting efficacy, and surgeon adoption patterns significantly influence market penetration across different healthcare systems

The rising global prevalence of osteoarthritis, rheumatoid arthritis, and sports-related injuries is expanding the pool of patients requiring post-operative rehabilitation, directly boosting CPM device demand. An aging demographic profile in developed and emerging economies alike is increasing the incidence of joint replacement surgeries, the primary clinical setting for CPM therapy utilization. Additionally, the growing preference for at-home rehabilitation, supported by portable device innovations and value-based care models that aim to reduce hospital stays, is accelerating adoption beyond traditional clinical environments.

• •Increasing volumes of knee and hip arthroplasty procedures, driven by aging populations and rising obesity rates, remain the largest demand catalyst
• •Clinical guidelines emphasizing early post-operative mobilization to prevent complications such as deep vein thrombosis and joint stiffness support continued prescription of CPM therapy
• •Technological improvements enabling smaller, more affordable, and patient-friendly portable CPM units are expanding market reach into home-care and outpatient settings

By joint type, knee joint devices command the largest market share due to the high global volume of knee arthroplasty procedures, while shoulder joint devices represent a growing segment fueled by rising shoulder surgery rates and aging rotator cuff populations. Hip joint devices hold a smaller but expanding share as hip replacement procedures increase globally. Device design splits the market into fixed, clinic-based units and portable/home-use variants, with portable devices gaining share as home rehabilitation becomes more common. Regionally, North America leads the market driven by high surgical volumes, favorable reimbursement, and advanced healthcare infrastructure, while Asia-Pacific is projected as the fastest-growing region due to improving healthcare access, rising disposable incomes, and growing medical tourism in countries such as India, China, and Japan.

• •North America accounts for the largest regional share, supported by high orthopedic procedure volumes and established clinical adoption of CPM therapy
• •Europe represents the second-largest market, with Western European nations driving demand through universal healthcare coverage and aging populations
• •Asia-Pacific is the most rapidly expanding region, reflecting rising healthcare expenditure, increasing awareness of post-operative rehabilitation, and expanding hospital infrastructure in emerging economies

What are the recent trends and outlook?

The market is moving toward smarter, more connected CPM devices that integrate with mobile applications and telehealth platforms, enabling clinicians to remotely monitor patient compliance and adjust therapy parameters without in-person visits. Portable and lightweight designs are gaining prominence as healthcare systems prioritize outpatient and home-based care models to control costs and improve patient comfort. As evidence supporting CPM efficacy continues to evolve, manufacturers are investing in clinical research to differentiate their products and secure favorable positioning in evidence-based treatment guidelines. Looking forward, the market's projected growth trajectory through 2030 will be shaped by the convergence of aging demographics, expanding indications for joint surgery, and the ongoing shift toward decentralized rehabilitation delivery models.

• •Integration of IoT connectivity and mobile app monitoring into CPM devices is enabling remote therapy oversight and data-driven treatment adjustments
• •Demand for compact, battery-operated portable CPM units suitable for home use is rising as healthcare providers seek alternatives to prolonged clinical stays
• •Emerging market expansion, growing medical tourism, and increased insurance coverage for post-operative rehabilitation are expected to sustain double-digit growth rates in select Asia-Pacific and Latin American regions